Dialogue with patients and the public health communities is crucial in enhancing pharmaceutical innovation

• In: G2 - Regulatory dialogue in building sustainable environment for pharma innovation on Monday, 30 August 2010, 9:00-12:00
• At: Lisbon (Portugal) (2010)
• Type: Presentation
• By: BAHRI, Priya (European Medicines Agency, London, United Kingdom)
• Abstract:

  While pharmaceutical sciences are centred around medicines, pharmaceutical activities should have the patient in the centre. Concerns over health, therapy and disease prevention origin from individuals who pursue a healthy life and as much quality of life as their physical conditions allow. It is acknowledged that patients take responsibility for

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login